456 related articles for article (PubMed ID: 22139728)
1. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T; Hikita A; Inoue Y
Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
[TBL] [Abstract][Full Text] [Related]
2. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
3. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
Sengupta S; Jana S; Bhattacharyya A
Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
[TBL] [Abstract][Full Text] [Related]
4. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
5. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.
Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC
Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
Räsänen K; Vaheri A
J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
9. [TGF-beta signaling during bone metastasis of breast cancer and in-vivo imaging].
Imamura T; Hanyu A
Clin Calcium; 2008 Apr; 18(4):460-5. PubMed ID: 18379027
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
11. EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.
Park CY; Son JY; Jin CH; Nam JS; Kim DK; Sheen YY
Eur J Cancer; 2011 Nov; 47(17):2642-53. PubMed ID: 21852112
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
13. ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.
Vendrell JA; Thollet A; Nguyen NT; Ghayad SE; Vinot S; Bièche I; Grisard E; Josserand V; Coll JL; Roux P; Corbo L; Treilleux I; Rimokh R; Cohen PA
Cancer Res; 2012 Jul; 72(14):3593-606. PubMed ID: 22593193
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
Kim ES; Kim MS; Moon A
Int J Oncol; 2004 Nov; 25(5):1375-82. PubMed ID: 15492828
[TBL] [Abstract][Full Text] [Related]
16. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition.
Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555
[TBL] [Abstract][Full Text] [Related]
17. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
Lee HS; Kim C; Kim SB; Kim MG; Park D
Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
20. Smad4-independent TGF-beta signaling in tumor cell migration.
Giehl K; Imamichi Y; Menke A
Cells Tissues Organs; 2007; 185(1-3):123-30. PubMed ID: 17587818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]